Company · CIK 0001651308 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
BeOne Medicines Ltd. · ONC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 10, 4:49 pm EDT | Xiaodong WangDirector | 31,027 | $36.90 | $1,144,896 | 31,027 | — | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 10, 4:49 pm EDT | Xiaodong WangDirector | 38,287 | $349.10 | $13,366,092 | 0 | −100% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 5:17 pm EDT | Titus B. BallPrincipal Accounting Officer | 132 | $355.86 | $46,974 | 0 | −100% | |
| Aug 25, 2026 SForm 4 → | Aug 27, 5:12 pm EDT | Xiaobin WuPresident and COO | 280 | $380.00 | $106,400 | 0 | −100% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 8:54 pm EDT | Chan Henry LeeSVP, General Counsel | 2,666 | $360.00 | $959,760 | 0 | −100% | 10b5-1 |
| Aug 11, 2026 MForm 4 → | Aug 13, 8:54 pm EDT | Chan Henry LeeSVP, General Counsel | 2,666 | $191.37 | $510,190 | 2,666 | — | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 12, 5:53 pm EDT | John OylerChief Executive Officer, Director | 240,810 | $359.12 | $86,480,472 | 0 | −100% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 5:15 pm EDT | Aaron RosenbergChief Financial Officer | 1,157 | $312.72 | $361,811 | 0 | −100% | |
| Jul 30, 2026 SForm 4 → | Aug 3, 5:18 pm EDT | Chan Henry LeeSVP, General Counsel | 1,044 | $323.69 | $337,932 | 0 | −100% | |
| Jul 22, 2026 SForm 4 → | Jul 24, 4:51 pm EDT | Chan Henry LeeSVP, General Counsel | 1,669 | $325.00 | $542,425 | 0 | −100% | 10b5-1 |
| Jul 22, 2026 MForm 4 → | Jul 24, 4:51 pm EDT | Chan Henry LeeSVP, General Counsel | 1,669 | $191.58 | $319,740 | 1,669 | — | 10b5-1 |
| Jul 20, 2026 MForm 4 → | Jul 22, 5:03 pm EDT | John OylerChief Executive Officer, Director | 33,990 | $119.96 | $4,077,440 | 33,990 | — | 10b5-1 |
| Jul 20, 2026 SForm 4 → | Jul 22, 5:03 pm EDT | John OylerChief Executive Officer, Director | 109,713 | $315.28 | $34,590,855 | 0 | −100% | 10b5-1 |
| Jul 17, 2026 SForm 4 → | Jul 17, 5:36 pm EDT | John OylerChief Executive Officer, Director | 64,628 | $312.00 | $20,163,907 | 0 | −100% | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 17, 5:36 pm EDT | John OylerChief Executive Officer, Director | 64,628 | $119.96 | $7,752,775 | 64,628 | — | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 17, 5:31 pm EDT | John OylerChief Executive Officer, Director | 283,154 | $315.56 | $89,351,598 | 0 | −100% | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 5:31 pm EDT | John OylerChief Executive Officer, Director | 283,154 | $145.28 | $41,137,996 | 166,597 | — | 10b5-1 |
| Jul 14, 2026 MForm 4 → | Jul 14, 9:26 pm EDT | John OylerChief Executive Officer, Director | 133,600 | $54.06 | $7,222,959 | 133,600 | — | 10b5-1 |
| Jul 14, 2026 SForm 4 → | Jul 14, 9:26 pm EDT | John OylerChief Executive Officer, Director | 145,861 | $305.95 | $44,626,424 | 0 | −100% | 10b5-1 |
| Jul 10, 2026 SForm 4 → | Jul 14, 9:25 pm EDT | John OylerChief Executive Officer, Director | 60,218 | $303.18 | $18,256,808 | 0 | −100% | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 14, 9:25 pm EDT | John OylerChief Executive Officer, Director | 60,218 | $36.90 | $2,222,044 | 48,520 | — | 10b5-1 |
| Jul 8, 2026 SForm 4 → | Jul 10, 4:44 pm EDT | Chan Henry LeeSVP, General Counsel | 664 | $302.46 | $200,833 | 0 | −100% | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 10, 4:44 pm EDT | Chan Henry LeeSVP, General Counsel | 664 | $191.56 | $127,196 | 664 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 10, 4:49 pm EDT | Xiaodong WangDirector | 403,351 | — | — | 1,210,079 | — | 10b5-1 |
| Aug 11, 2026 MForm 4 → | Aug 13, 8:54 pm EDT | Chan Henry LeeSVP, General Counsel | 34,658 | — | — | 88,582 | — | 10b5-1 |
| Jul 22, 2026 MForm 4 → | Jul 24, 4:51 pm EDT | Chan Henry LeeSVP, General Counsel | 21,697 | — | — | 98,930 | — | 10b5-1 |
| Jul 20, 2026 MForm 4 → | Jul 22, 5:03 pm EDT | John OylerChief Executive Officer, Director | 441,870 | — | — | 0 | — | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 17, 5:36 pm EDT | John OylerChief Executive Officer, Director | 840,164 | — | — | 441,870 | — | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 5:31 pm EDT | John OylerChief Executive Officer, Director | 3,681,002 | — | — | 1,282,034 | — | 10b5-1 |
| Jul 14, 2026 MForm 4 → | Jul 14, 9:26 pm EDT | John OylerChief Executive Officer, Director | 1,736,800 | — | — | 462,866 | — | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 14, 9:25 pm EDT | John OylerChief Executive Officer, Director | 782,834 | — | — | 1,264,666 | — | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 10, 4:44 pm EDT | Chan Henry LeeSVP, General Counsel | 8,632 | — | — | 105,300 | — | 10b5-1 |